Evaluation of the effect of Lactofem probiotic supplement on sexual function in patients with polycystic ovary syndrome
Phase 3
- Conditions
- polycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
- Registration Number
- IRCT20160524028038N18
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 480
Inclusion Criteria
age 18 to 40 years
Confirmation of polycystic ovary syndrome based on the Rotterdam criteria
Iranian
Absence of severe mental conditions since six months before the research
Not suffering from severe depression and anxiety according to the depression and anxiety questionnaire
No language or cognitive problems preventing the patient from completing the questionnaire
No current use of drugs affecting sexual function
No smoking
Failure to previously diagnose an organic cause for sexual dysfunction by an experienced physician
No current use of psychiatric medications
Currently taking cyproterone compound tablets as prescribed by the gynecologist
Exclusion Criteria
Patients who do not want to cooperate
Pregnancy during study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sexual function. Timepoint: Before the intervention and three after the intervention. Method of measurement: FSFI sexual function questionnaire.
- Secondary Outcome Measures
Name Time Method